White House Pivots Health Strategy as Midterm Realities Constrain Kennedy’s MAHA Agenda

President Trump shifts HHS focus away from RFK Jr.’s vaccine and pesticide targets toward drug pricing and nutrition to secure GOP support for the 2026 midterms.

By: AXL Media

Published: Feb 21, 2026, 11:02 AM EST

Source: Information for this report was sourced from Politico

The Executive Order on Glyphosate and Tactical Shifts

The most prominent sign of Kennedy's waning influence came this week when President Trump issued an executive order aimed at boosting the production of glyphosate, a widely used herbicide that Kennedy has long labeled a carcinogen. While Kennedy and his followers view the chemical as a public health threat, the administration framed the move as a necessity for national security and agricultural independence from foreign actors like China. Lobbyists in Washington noted that "picking on farmers" a foundational segment of the Republican base is considered a strategic error during an election year. Consequently, the administration is prioritizing the stability of the domestic food supply chain over Kennedy’s anti-chemical advocacy.

Reshuffling Leadership to Focus on Popular Health Policy

A major management shakeup at HHS last week further signaled a move away from controversial vaccine policies. The White House dismissed Kennedy’s second-in-command, Jim O’Neill, and General Counsel Mike Stuart, replacing them with officials focused on drug pricing and administrative efficiency. Chris Klomp, who previously led the administration’s drug pricing efforts, has been promoted to oversee all HHS operations. This restructuring is designed to emphasize the administration's claims of lowering medicine costs, a key issue for voters while sidelining Kennedy’s push to downsize the childhood immunization schedule, which recent polling suggests remains unpopular even among many Republican parents.

TRANSFORMATIVE ANALYSIS: The Lobbying Power Gap in DC

The pivot toward food industry regulation over the pharmaceutical and chemical sectors highlights a stark disparity in lobbying power within Washington. In 2025, the pharmaceutical industry (PhRMA) spent a record $38 million on lobbying, while the American Chemistry Council spent nearly $19 million. In contrast, the food and beverage industry spent less than $11 million combined. This financial reality makes the food industry a much "softer" target for the MAHA movement's reform efforts. By focusing Kennedy on ultraprocessed foods and fitness illustrated by recent viral videos featuring celebrities like Kid Rock and Mike Tyson the administration can deliver "wins" for the MAHA base without triggering an expensive and politically damaging war with the better-funded pharma an...